SCHEMBL973729

SCHEMBL973729

CCCCCCCCCCC=C(C#N)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.58
PPARG P37231 8/20 0.44
PPARA Q07869 3/20 0.44
TRPA1 O75762 1/20 0.44
FBP1 P09467 1/20 0.44
TERT O14746 3/20 0.43
MAPT P10636 2/20 0.43
BLM P54132 2/20 0.43
HSD17B10 Q99714 2/20 0.43
FABP4 P15090 2/20 0.43
GMNN O75496 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
APEX1 P27695 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744949 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL142755 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL154904 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL423102 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL1602959 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL3149613 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL1274680 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL29047 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL7568098 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1
SCHEMBL9361054 1.00 EP300 (0.58) EP300PPARGPPARATRPA1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9752049-B2 Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same UT-BATTELLE, LLC (US) 2017-09-05 US claimed
US-20150232690-A1 OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME UT-BATTELLE, LLC (US) 2015-08-20 US claimed
US-20110020251-A1 Ultraviolet-Absorbing Compounds AVOCA LLC 2011-01-27 US claimed
EP-1455738-B1 USE OF ELECTROPHILIC MONOMERS FOR HAIR TREATMENT OREAL (FR) 2010-07-28 EP claimed
EP-1633255-B1 DUAL-ENDED APPLICATOR FOR DISPENSING TWO FLUIDS, IN PARTICULAR GLUE COMPONENTS MEDLOGIC GLOBAL LTD (GB) 2008-02-20 EP claimed
EP-1360257-B1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS LOCTITE R & D LTD (IE) 2007-07-25 EP claimed
US-6977278-B1 Cyanoacrylate compositions curable to flexible polymeric materials LOCTITE (R&D) LTD. (IE) 2005-12-20 US claimed
WO-2004024467-A2 SURFACE-MOUNTING SYSTEM LOCTITE (R & D) LIMITED (IE) 2004-03-25 WO claimed
CN-114126838-A 3D printing method and system 波士胶公司 2022-03-01 CN disclosed
EP-3947586-A1 FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2022-02-09 EP disclosed
US-20220033544-A1 FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2022-02-03 US disclosed
WO-2020206405-A1 FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2020-10-08 WO disclosed
EP-2999689-B1 CYANOACRYLATE COMPOSITIONS Henkel IP & Holding GmbH (DE) 2017-10-04 EP disclosed
US-9752049-B2 Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same UT-BATTELLE, LLC (US) 2017-09-05 US disclosed
US-5348991-A N-oxycarbonylacrylamide resin NIPPON PAINT CO., LTD. (JP) 1994-09-20 US disclosed
EP-0431554-B1 Cationic electrocoating composition NIPPON PAINT CO LTD (JP) 1994-04-06 EP disclosed
EP-0431554-A2 Cationic electrocoating composition NIPPON PAINT CO., LTD. (JP) 1991-06-12 EP disclosed
EP-0413352-A2 Solvent based coating composition Nippon Paint Co., Ltd. (JP) 1991-02-20 EP disclosed
EP-0413351-A2 Aqueous dispersion coating composition Nippon Paint Co., Ltd. (JP) 1991-02-20 EP disclosed
US-4199915-A Anerobic adhesive package and method for the production thereof LEVINE HARRIS D 1980-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110020251-A1 Ultraviolet-Absorbing Compounds UFM1, UHRF1, CUTA EP300 366/4885PPARG 3304/4885PPARA 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.